3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Cancer Pain
9
Neoplasms
6
Pain
4
Prostatic Neoplasms
1
Osteoarthritis
1
Opioid-Induced Constipation
1
Lymphoma, Follicular
1
Inflammation
1
Head and Neck Neoplasms
1
Endobronchial Metastases
1
Chronic Pain
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Back Pain
1
Agnosia
1
Acute Pain
1
Interventions
Zoledronic Acid
14
Leuprolide
9
bicalutamide
6
Triptorelin Pamoate
6
Goserelin
6
luprolide acetate gel depot
5
enzalutamide
5
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
5
Dutasteride
5
fluciclovine F-18
3
darolutamide
3
Sodium Chloride
3
Prednisone
3
Magnetic Resonance Spectroscopy
3
Flutamide
3
Androgen Antagonists
3
Abiraterone Acetate
3
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
3
cabazitaxel
2
Propofol
2
Prednisolone
2
Lidocaine
2
Gonadotropin-Releasing Hormone
2
Finasteride
2
Dexamethasone
2
Desflurane
2
Ciprofloxacin
2
testosterone 17 beta-cypionate
1
semaglutide
1
polyethylene glycol 3350
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Prostatic Neoplasms
×
Oxycodone
×
Clear all
NCT07001709
2025-06-03
ENABLE
Deventer Ziekenhuis
Phase 4
Recruiting
29 enrolled